Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc.verified

IPCIF

Price:

$0.15

Market Cap:

$4.96M

Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for hyperactivity disorder; Keppra XR, a levetiracetam extended-release tablet for the treatment of partial onset seizures in patients with epilepsy; Eff...[Read more]

Industry

Biotechnology

IPO Date

2009-10-26

Stock Exchange

OTC

Ticker

IPCIF

The PE Ratio as of November 2025 (TTM) for Intellipharmaceutics International Inc. (IPCIF) is -1.67

According to Intellipharmaceutics International Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.67. This represents a change of -41.25% compared to the average of -2.84 of the last 4 quarters.

Intellipharmaceutics International Inc. (IPCIF) Historical PE Ratio (quarterly & annually)

How has IPCIF PE Ratio performed in the past?

The mean historical PE Ratio of Intellipharmaceutics International Inc. over the last ten years is -4.46. The current -1.67 PE Ratio has changed 3.63% with respect to the historical average. Over the past ten years (40 quarters), IPCIF's PE Ratio was at its highest in in the February 2014 quarter at 10.02. The PE Ratio was at its lowest in in the February 2015 quarter at -15.94.

Quarterly (TTM)
Annual

Average

-4.46

Median

-2.09

Minimum

-17.21

Maximum

-0.11

Intellipharmaceutics International Inc. (IPCIF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Intellipharmaceutics International Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 734.53%

Maximum Annual PE Ratio = -0.11

Minimum Annual Increase = -96.12%

Minimum Annual PE Ratio = -17.21

Quarterly (TTM)
Annual
YearPE RatioChange
2022-0.80-34.41%
2021-1.22105.10%
2020-0.60-37.64%
2019-0.95734.53%
2018-0.11-96.12%
2017-2.95-59.83%
2016-7.349.41%
2015-6.71-61.01%
2014-17.21155.32%
2013-6.74-0.93%

Intellipharmaceutics International Inc. (IPCIF) Average PE Ratio

How has IPCIF PE Ratio performed in the past?

The current PE Ratio of Intellipharmaceutics International Inc. (IPCIF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.87

5-year avg

-0.74

10-year avg

-4.46

Intellipharmaceutics International Inc. (IPCIF) PE Ratio vs. Peers

How is IPCIF’s PE Ratio compared to its peers?

Intellipharmaceutics International Inc.’s PE Ratio is less than Tryp Therapeutics Inc. (-1.10), less than BerGenBio ASA (-0.43), less than Acreage Holdings, Inc. (-0.01), greater than China Infrastructure Construction Corp. (-17.39), less than Acreage Holdings, Inc. (-0.01), greater than Pascal Biosciences Inc. (-9.01), less than Indiva Limited (-1.06), greater than Dogecoin Cash, Inc. (-1.84), less than Rhinomed Limited (-1.05), greater than Pixium Vision S.A. (-1.92),

Build a custom stock screener for Intellipharmaceutics International Inc. (IPCIF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Intellipharmaceutics International Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Intellipharmaceutics International Inc. (IPCIF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Intellipharmaceutics International Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Intellipharmaceutics International Inc.'s PE Ratio?

How is the PE Ratio calculated for Intellipharmaceutics International Inc. (IPCIF)?

What is the highest PE Ratio for Intellipharmaceutics International Inc. (IPCIF)?

What is the 3-year average PE Ratio for Intellipharmaceutics International Inc. (IPCIF)?

What is the 5-year average PE Ratio for Intellipharmaceutics International Inc. (IPCIF)?

How does the current PE Ratio for Intellipharmaceutics International Inc. (IPCIF) compare to its historical average?